Holen Sie sich die Stockscreener-App
372.82
3.34%
-12.88
Vorhandelsmarkt:
373.61
0.79
+0.21%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt HUM?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$385.70
Offen:
$386.51
24-Stunden-Volumen:
727.60K
Relative Volume:
0.48
Marktkapitalisierung:
$44.76B
Einnahmen:
$137.20B
Nettoeinkommen (Verlust:
$1.15B
KGV:
39.90
EPS:
9.3439
Netto-Cashflow:
$1.27B
1W Leistung:
+2.94%
1M Leistung:
-4.95%
6M Leistung:
+112.55%
1J Leistung:
+39.81%
1-Tages-Spanne:
$371.96
$389.53
1-Wochen-Bereich:
$353.69
$393.48
52-Wochen-Spanne:
$163.11
$428.88
Humana Inc Stock (HUM) Company Profile
Firmenname
Humana Inc
Sektor
Branche
Telefon
(502) 580-1000
Adresse
101 E. MAIN STREET, LOUISVILLE, KY
Compare HUM vs UNH, CVS, ELV, CI
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HUM
Humana Inc
|
372.82 | 45.76B | 137.20B | 1.15B | 1.27B | 9.3439 |
UNH
Unitedhealth Group Inc
|
402.19 | 379.28B | 450.13B | 14.91B | 23.62B | 15.55 |
CVS
Cvs Health Corp
|
93.50 | 136.61B | 407.94B | 2.90B | 7.39B | 2.2771 |
ELV
Elevance Health Inc
|
390.37 | 82.05B | 201.11B | 4.95B | 6.29B | 22.50 |
CI
Cigna Group
|
273.87 | 76.98B | 278.13B | 6.74B | 7.66B | 23.60 |
Humana Inc Stock (HUM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-12 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2026-02-02 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2026-01-07 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-12-05 | Hochstufung | Jefferies | Hold → Buy |
| 2025-10-14 | Eingeleitet | Goldman | Sell |
| 2025-09-22 | Eingeleitet | Evercore ISI | In-line |
| 2025-05-01 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2024-11-06 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2024-10-08 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2024-10-07 | Herabstufung | Jefferies | Buy → Hold |
| 2024-10-07 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-10-03 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-10-02 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-10-02 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-10-02 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2024-06-26 | Eingeleitet | Piper Sandler | Overweight |
| 2024-06-24 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-04-02 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-03-22 | Eingeleitet | Raymond James | Mkt Perform |
| 2024-03-13 | Herabstufung | Argus | Buy → Hold |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2024-01-26 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2024-01-25 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-12-12 | Hochstufung | Argus | Hold → Buy |
| 2023-11-08 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-07-07 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2023-06-23 | Herabstufung | Argus | Buy → Hold |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-12-13 | Hochstufung | Goldman | Neutral → Buy |
| 2022-10-26 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-09-20 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Eingeleitet | Bernstein | Mkt Perform |
| 2022-04-13 | Hochstufung | UBS | Neutral → Buy |
| 2022-01-06 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2021-12-16 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-12-14 | Eingeleitet | Goldman | Neutral |
| 2021-11-04 | Bestätigt | Barclays | Overweight |
| 2021-11-04 | Bestätigt | Credit Suisse | Outperform |
| 2021-11-04 | Bestätigt | Morgan Stanley | Overweight |
| 2021-11-04 | Bestätigt | Oppenheimer | Outperform |
| 2021-11-04 | Bestätigt | RBC Capital Mkts | Outperform |
| 2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-10 | Eingeleitet | Cowen | Outperform |
| 2021-09-09 | Fortgesetzt | Barclays | Overweight |
| 2021-07-09 | Eingeleitet | Seaport Global Securities | Neutral |
| 2021-05-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2021-01-04 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-10-02 | Eingeleitet | Bernstein | Mkt Perform |
| 2020-07-01 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-16 | Herabstufung | Cowen | Outperform → Market Perform |
| 2020-06-05 | Eingeleitet | Goldman | Buy |
| 2020-01-03 | Bestätigt | JP Morgan | Overweight |
| 2019-10-18 | Eingeleitet | Mizuho | Buy |
| 2019-09-30 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Hold |
| 2019-08-12 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2019-04-23 | Eingeleitet | UBS | Neutral |
| 2019-01-14 | Eingeleitet | Stephens | Overweight |
| 2018-12-20 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-11-08 | Bestätigt | BofA/Merrill | Buy |
| 2018-09-13 | Eingeleitet | Barclays | Overweight |
| 2018-07-12 | Fortgesetzt | Morgan Stanley | Overweight |
| 2018-07-06 | Bestätigt | Piper Jaffray | Overweight |
| 2018-06-01 | Fortgesetzt | Citigroup | Buy |
| 2018-02-08 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2018-02-08 | Bestätigt | Leerink Partners | Outperform |
| 2018-01-12 | Hochstufung | Jefferies | Hold → Buy |
Alle ansehen
Humana Inc Aktie (HUM) Neueste Nachrichten
Humana names new Medicaid president - The Business Journals
Humana Inc (HUM) Stock Down 3.3% but Still Overvalued -- GF Scor - GuruFocus
Glenmark settles Humana antitrust lawsuit for $15.28 million - scanx.trade
News by CNBC TV18 on TradingView, 2026-08-11 — cnbctv:35c78df51094b:0 - TradingView
Humana Healthy Horizons in Indiana Collaborates with HealthStream to Expand and Strengthen Home Care Workforce - Business Wire
Humana Names James P. Holland President of Medicaid - citybiz
Humana appoints James Holland to lead Medicaid business - Investing.com
Humana’s Incoming Medicaid President Will Lead Business in 11 States - Stock Titan
James P. Holland to Join Humana as Medicaid President - Caledonian Record
Bronstein, Gewirtz & Grossman, LLC Encourages Humana Inc. (HUM) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Humana Inc. $HUM Stock Position Decreased by Gradient Investments LLC - MarketBeat
Pacer Advisors Inc. Has $1.65 Million Stock Holdings in Humana Inc. $HUM - MarketBeat
180 Wealth Advisors LLC Cuts Stake in Humana Inc. $HUM - MarketBeat
Humana Inc. (HUM) Stock forecasts - Yahoo Finance Singapore
Humana Inc (HUM) Stock Up 4.8% but GF Value Says Overvalued -- G - GuruFocus
Humana Inc. stock outperforms competitors on strong trading day - MarketWatch
Quantinno Capital Management LP Cuts Stock Position in Humana Inc. $HUM - MarketBeat
ANTITRUST—E.D. Pa.: Humana’s generic-drug price-fixing claims will proceed to bellwether trial - VitalLaw.com
Bank of America Corp DE Decreases Holdings in Humana Inc. $HUM - MarketBeat
Drug Cos. Can't Trim Humana's Price-Fix Claims In Bellwether - law360.com
Humana Subsidiary iCare Selected for Family Care and Family Care Partnership Contracts Across Southeast Wisconsin - Business Wire
Glenmede Trust Co. NA Sells 3,698 Shares of Humana Inc. $HUM - MarketBeat
A Look at Humana Inc (HUM) After 3.3% Decline -- GF Value $366.9 - GuruFocus
Humana (NYSE: HUM) grants director $200,000 in restricted stock units - Stock Titan
Humana Inc. (HUM) Stock Forecasts - Yahoo Finance
The Manufacturers Life Insurance Company Reduces Stock Holdings in Humana Inc. $HUM - MarketBeat
Humana’s (HUM) Path to Recovery and Growth - Yahoo Finance
Humana Inc. (HUM) director gets $200,000 in restricted stock units - Stock Titan
Humana Community Day 2026 Mobilizes Thousands of Employees Nationwide to Support Healthier Communities - Business Wire
Janus Henderson Group PLC Raises Stock Holdings in Humana Inc. $HUM - MarketBeat
Humana Inc. (HUM) Stock Analysis: Evaluating Healthcare Growth with a 12% Upside Potential - DirectorsTalk Interviews
Humana Inc. (NYSE:HUM) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Amundi Purchases 37,501 Shares of Humana Inc. $HUM - MarketBeat
California State Teachers Retirement System Decreases Stock Holdings in Humana Inc. $HUM - MarketBeat
Humana Inc. $HUM Shares Sold by First Trust Advisors LP - MarketBeat
Empowered Funds LLC Sells 27,030 Shares of Humana Inc. $HUM - MarketBeat
Did Humana Inc. Insiders Breach their Fiduciary Duties to Shareholders? - PR Newswire
Humana: Q2 Earnings Snapshot - KING5.com
Humana Reports Second Quarter 2026 Financial Results; Affirms Full Year 2026 Adjusted Financial Guidance - Business Wire
Arrowstreet Capital Limited Partnership Raises Stock Holdings in Humana Inc. $HUM - MarketBeat
Q2 2026 Humana Inc Earnings Call Transcript - GuruFocus
Humana Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Humana earnings on deck as investors eye utilization trends By Investing.com - Investing.com Canada
Humana study suggests Medicare Advantage payments may be less affected - Stock Titan
The Zacks Analyst Blog Highlights CVS Health, Cardinal Health, Humana and ACADIA Pharmaceuticals - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Is Investigating Humana Inc. (HUM) And Encourages Investors to Connect - ACCESS Newswire
Cash flow from operating activities of Humana Inc. – HAM:HUM - TradingView
Humana Inc Agencies, 2024 - OpenSecrets
Net income before discontinued operations of Humana Inc. – HAM:HUM - TradingView
Humana Inc. stock underperforms Monday when compared to competitors - MarketWatch
4 Medical Stocks With the Right Setup for Q2 Earnings Beats - TradingView
Finanzdaten der Humana Inc-Aktie (HUM)
Umsatz
Nettogewinn
Free Cashflow
ENV
Humana Inc-Aktie (HUM) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Ventura Joseph C | Chief Legal Officer |
Feb 24 '26 |
Option Exercise |
0.00 |
1,035 |
0 |
17,565 |
| Renaudin George II | President, Insurance |
Feb 24 '26 |
Option Exercise |
0.00 |
1,035 |
0 |
16,494 |
| Felter John-Paul W. | SVP, Chief Accting Off & Cont. |
Feb 24 '26 |
Option Exercise |
0.00 |
165 |
0 |
7,568 |
| Shetty Sanjay K | President, CenterWell |
Feb 23 '26 |
Buy |
185.21 |
810 |
150,016 |
11,657 |
| Dintenfass David | President, Enterprise Growth |
Feb 21 '26 |
Option Exercise |
0.00 |
3,858 |
0 |
15,316 |
| Mehta Japan | Chief Information Officer |
Feb 13 '26 |
Option Exercise |
0.00 |
1,682 |
0 |
8,158 |
| Mellet Celeste | Chief Financial Officer |
Feb 13 '26 |
Option Exercise |
0.00 |
7,763 |
0 |
28,454 |
| Rechtin James A. | President & CEO |
Jan 08 '26 |
Option Exercise |
0.00 |
2,183 |
0 |
29,285 |
| O'Hara Michelle A. | Chief Human Resources Officer |
Jan 01 '26 |
Option Exercise |
0.00 |
2,353 |
0 |
10,634 |
| Mellet Celeste | Chief Financial Officer |
Dec 15 '25 |
Option Exercise |
0.00 |
2,128 |
0 |
29,676 |
0.04%
2.54%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):